Scharmann U, Verhasselt H, Kirchhoff L, Furnica D, Steinmann J, Rath P
Diagnostics (Basel). 2023; 13(16).
PMID: 37627977
PMC: 10453445.
DOI: 10.3390/diagnostics13162718.
Happacher I, Aguiar M, Yap A, Decristoforo C, Haas H
Essays Biochem. 2023; 67(5):829-842.
PMID: 37313590
PMC: 10500206.
DOI: 10.1042/EBC20220252.
Dobias R, Stevens D, Havlicek V
Antibiotics (Basel). 2023; 12(2).
PMID: 36830296
PMC: 9952630.
DOI: 10.3390/antibiotics12020385.
Luptakova D, Patil R, Dobias R, Stevens D, Pluhacek T, Palyzova A
Microbiol Spectr. 2023; :e0406822.
PMID: 36719229
PMC: 10100950.
DOI: 10.1128/spectrum.04068-22.
Aguiar M, Orasch T, Shadkchan Y, Caballero P, Pfister J, Sastre-Velasquez L
mBio. 2022; 13(5):e0219222.
PMID: 36125294
PMC: 9600649.
DOI: 10.1128/mbio.02192-22.
Existing tests vs. novel non-invasive assays for detection of invasive aspergillosis in patients with respiratory diseases.
Xiao W, Du L, Cai L, Miao T, Mao B, Wen F
Chin Med J (Engl). 2022; .
PMID: 35861304
PMC: 9532040.
DOI: 10.1097/CM9.0000000000002050.
The Siderophore Transporters Sit1 and Sit2 Are Essential for Utilization of Ferrichrome-, Ferrioxamine- and Coprogen-Type Siderophores in .
Aguiar M, Orasch T, Misslinger M, Dietl A, Gsaller F, Haas H
J Fungi (Basel). 2021; 7(9).
PMID: 34575806
PMC: 8470733.
DOI: 10.3390/jof7090768.
and aspergillosis: From basics to clinics.
Arastehfar A, Carvalho A, Houbraken J, Lombardi L, Garcia-Rubio R, Jenks J
Stud Mycol. 2021; 100:100115.
PMID: 34035866
PMC: 8131930.
DOI: 10.1016/j.simyco.2021.100115.
Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement.
Jenks J, Gangneux J, Schwartz I, Alastruey-Izquierdo A, Lagrou K, Thompson Iii G
J Fungi (Basel). 2020; 6(4).
PMID: 33050598
PMC: 7712958.
DOI: 10.3390/jof6040216.
Current State of the Diagnosis of Invasive Pulmonary Aspergillosis in Lung Transplantation.
Herrera S, Husain S
Front Microbiol. 2019; 9:3273.
PMID: 30687264
PMC: 6333628.
DOI: 10.3389/fmicb.2018.03273.
Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis.
Hoenigl M, Orasch T, Faserl K, Prattes J, Loeffler J, Springer J
J Infect. 2018; 78(2):150-157.
PMID: 30267801
PMC: 6361682.
DOI: 10.1016/j.jinf.2018.09.006.
Treatment of Aspergillosis.
Jenks J, Hoenigl M
J Fungi (Basel). 2018; 4(3).
PMID: 30126229
PMC: 6162797.
DOI: 10.3390/jof4030098.
Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.
Heldt S, Prattes J, Eigl S, Spiess B, Flick H, Rabensteiner J
J Infect. 2018; 77(3):235-241.
PMID: 29972764
PMC: 6097945.
DOI: 10.1016/j.jinf.2018.05.001.
Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.
Jenks J, Salzer H, Prattes J, Krause R, Buchheidt D, Hoenigl M
Drug Des Devel Ther. 2018; 12:1033-1044.
PMID: 29750016
PMC: 5933337.
DOI: 10.2147/DDDT.S145545.
[Aspergillus in airway material : Ignore or treat?].
Salzer H, Lange C, Honigl M
Internist (Berl). 2017; 58(11):1150-1162.
PMID: 28986661
DOI: 10.1007/s00108-017-0334-9.
Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status.
Heldt S, Hoenigl M
Curr Fungal Infect Rep. 2017; 11(2):45-51.
PMID: 28680526
PMC: 5487869.
DOI: 10.1007/s12281-017-0275-8.